These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18772589)

  • 1. Evaluation of killing kinetics of anti-tuberculosis drugs on Mycobacterium tuberculosis using a bacteriophage-based assay.
    Marcel N; Nahta A; Balganesh M
    Chemotherapy; 2008; 54(5):404-11. PubMed ID: 18772589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs.
    Bax HI; Bakker-Woudenberg IAJM; de Vogel CP; van der Meijden A; Verbon A; de Steenwinkel JEM
    Tuberculosis (Edinb); 2017 Jul; 105():80-85. PubMed ID: 28610791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity of OPC-67683 against drug-tolerant Mycobacterium tuberculosis.
    Saliu OY; Crismale C; Schwander SK; Wallis RS
    J Antimicrob Chemother; 2007 Nov; 60(5):994-8. PubMed ID: 17761500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
    Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
    J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
    Taneja NK; Tyagi JS
    J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
    Darby CM; Nathan CF
    J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109.
    de Knegt GJ; van der Meijden A; de Vogel CP; Aarnoutse RE; de Steenwinkel JE
    Int J Antimicrob Agents; 2017 Mar; 49(3):302-307. PubMed ID: 28162983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
    Matee M; Mfinanga S; Holm-Hansen C
    APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection of resistant tuberculosis by nitrate reductase assay performed in three settings in Brazil.
    Shikama Mde L; Silva RR; Martins MC; Giampaglia CM; Oliveira RS; Silva RF; Silva PF; Telles MA; Martin A; Palomino JC
    J Antimicrob Chemother; 2009 Oct; 64(4):794-6. PubMed ID: 19671589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct drug susceptibility testing of Mycobacterium tuberculosis to primary anti-tubercular drugs by nitrate reductase assay.
    Mishra B; Muralidharan S; Srinivasa H
    Indian J Pathol Microbiol; 2009; 52(3):343-4. PubMed ID: 19679956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua.
    Chacón L; Lainez M; Rosales E; Mercado M; Caminero JA
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):62-7. PubMed ID: 19105880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB).
    Martins M; Viveiros M; Ramos J; Couto I; Molnar J; Boeree M; Amaral L
    Int J Antimicrob Agents; 2009 May; 33(5):479-82. PubMed ID: 19155160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs.
    Coleman D; Waddell SJ; Mitchison DA
    J Antimicrob Chemother; 2011 Jan; 66(1):146-50. PubMed ID: 21071459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
    Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
    Martins M; Viveiros M; Couto I; Amaral L
    Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
    Ozkütük N; Ecemiş T; Sürücüoğlu S
    Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistant tuberculosis in Egyptian children using Etest.
    Morcos W; Morcos M; Doss S; Naguib M; Eissa S
    Minerva Pediatr; 2008 Dec; 60(6):1385-92. PubMed ID: 18971899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibility testing of Mycobacterium tuberculosis isolates to primary antituberculous drugs on chocolate agar: a preliminary study].
    Coban AY; Bilgin K; Akgüneş A; Durupinar B
    Mikrobiyol Bul; 2008 Jul; 42(3):477-81. PubMed ID: 18822892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.